Category: Current Studies

Zambart is leading the operational research task of the USAID-sponsored Eradicate TB project (ETB). From 2017-2021, ETB will work in partnership with the National Tuberculosis Program (NTP) to halve TB-related mortality in the 6 northern provinces by the year 2022.…

YATHU YATHU: FOR US BY US In 2015, adolescents and young people (AYP) accounted for 37% of new HIV infections, with young women aged 15-24 years having the highest HIV incidence rates globally, and in Southern Africa, a  high number…

What is the STAR Study? The acronym STAR is for Self-testing AfRica. HIV Self Testing (HIVST) is a new phenomenon in Africa and has the potential to reach the unreached population who are not aware of their status. Despite this…

Zambart is one of the study sites for a Phase IIb trial of a new TB vaccine. The trial is being conducted by Aeras and GlaxoSmithKline Vaccines, S.A. (GSK) and is a double-blind randomised, placebo controlled study. (Clinical Trail.gov Identifier:…

Please click here for news on the TREAT study.

HIV infection remains at a very high level in Zambia. The national HIV prevalence rate among adults 15-49 years currently stands at 14.3% (2007 ZDHS). Although this represents a slight decrease from the 15.6% prevalence observed in the 2001-02 ZDHS,…